Publish date: 16 November 2023

To GPs who use the Health Service Laboratories (HSL) Virology/Serology service,

Following a clinical review and significant reduction in test volume, we’d like to inform you that HSL will no longer offer the Roche anti-N (nucleocapsid) SARS-CoV-2 assay effective 1st December 2023.

HSL will continue to offer the Roche quantitative anti-S (spike) SARS-CoV-2 assay as this is required by NHSE to determine whether a patient is eligible for monoclonal antibody treatment.

If the Roche anti-N (nucleocapsid) SARS-CoV-2 assay is required for research purposes, HSL can support this request via HSL R&D, however the assay will not be UKAS accredited.

For any queries or further information please contact 

wendy.chatterton@hslpathology.com